BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8395201)

  • 1. Intraconazole--a new oral antifungal agent with a very broad spectrum of activity in superficial and systemic mycoses.
    Odds FC
    J Dermatol Sci; 1993 Apr; 5(2):65-72. PubMed ID: 8395201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models.
    Van Cutsem J; Van Gerven F; Janssen PA
    Rev Infect Dis; 1987; 9 Suppl 1():S15-32. PubMed ID: 3027843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.
    Grant SM; Clissold SP
    Drugs; 1989 Mar; 37(3):310-44. PubMed ID: 2540949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral, topical and parenteral antifungal treatment with itraconazole in normal and in immunocompromised animals.
    Van Cutsem J
    Mycoses; 1989; 32 Suppl 1():14-34. PubMed ID: 2561183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tropical mycoses].
    Bayles MA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():13-9. PubMed ID: 1663201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropical mycoses.
    Bayles MA
    Chemotherapy; 1992; 38 Suppl 1():27-34. PubMed ID: 1319312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In-vitro and in-vivo activity of itraconazole].
    Van Cutsem J
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer developments in therapy for endemic mycoses.
    Kauffman CA
    Clin Infect Dis; 1994 Aug; 19 Suppl 1():S28-32. PubMed ID: 7948568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European experience with itraconazole in systemic mycoses.
    Viviani MA; Tortorano AM; Pagano A; Vigevani GM; Gubertini G; Cristina S; Assaisso ML; Suter F; Farina C; Minetti B
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):587-93. PubMed ID: 2170478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and parenteral treatment with itraconazole in various superficial and systemic experimental fungal infections. Comparisons with other antifungals and combination therapy.
    Van Cutsem J
    Br J Clin Pract Suppl; 1990 Sep; 71():32-40. PubMed ID: 1965417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The therapeutic effects of itraconazole, a new triazole antifungal agent, for experimental fungal infections].
    Uchida K; Yamaguchi H; Shibuya K
    Jpn J Antibiot; 1991 May; 44(5):588-99. PubMed ID: 1652657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole, a new triazole that is orally active in aspergillosis.
    Van Cutsem J; Van Gerven F; Van de Ven MA; Borgers M; Janssen PA
    Antimicrob Agents Chemother; 1984 Oct; 26(4):527-34. PubMed ID: 6097167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycoses as opportunistic infections in AIDS patients].
    Viviani MA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():19-22. PubMed ID: 1663202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral azole drugs as systemic antifungal therapy.
    Como JA; Dismukes WE
    N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Itraconazole.
    Piérard GE; Arrese JE; Piérard-Franchimont C
    Expert Opin Pharmacother; 2000 Jan; 1(2):287-304. PubMed ID: 11249550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
    De Rosso JQ; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial experience in therapy for progressive mycoses with itraconazole, the first clinically studied triazole.
    Ganer A; Arathoon E; Stevens DA
    Rev Infect Dis; 1987; 9 Suppl 1():S77-86. PubMed ID: 3027851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole: a new triazole antifungal agent.
    Zuckerman JM; Tunkel AR
    Infect Control Hosp Epidemiol; 1994 Jun; 15(6):397-410. PubMed ID: 8083506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Itraconazole in the treatment of human mycoses: review of three years of clinical experience.
    Cauwenbergh G; De Doncker P; Stoops K; De Dier AM; Goyvaerts H; Schuermans V
    Rev Infect Dis; 1987; 9 Suppl 1():S146-52. PubMed ID: 3027842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.